January 2020

 

 

academics

 

Clinical research courses

5 January 2020

Applications are invited for the post of Program Manager at JIPMER

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) can trace its origins to the ‘Ecole de Medicine de Pondicherry’ established by the French Government in 1823. In 1956 foundation for new medical college was laid and in 1964, hospital was inaugurated. JIPMER became an institution of national importance under the Ministry of Health and Family Welfare, Government of India in the year 2008. It is an institution established for teaching, research and patient care in the area of health.

5 January 2020
Vacancy for B.Pharm, B.Sc as Territory Business Manager at Abbott India

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

5 January 2020
Job for Associate Professor at Moradabad Educational Trust

MORADABAD EDUCATIONAL TRUST (MET) was established in the year 1996 and started 4 years degree course in Pharmacy in the year 2009 (B. Pharm) under the banner of Faculty of Pharmacy. Subsequently Diploma in Pharmacy will start from the Academic Session 2018-19. The Institute is situated on the bank of holy river Ram Ganga in the Brass city of India (Moradabad). The College is approved by AICTE, PCI, New Delhi and affiliated to Dr. A. P. J.

Risk of central nervous system adverse events

New Zealand. Medsafe has announced that the higher dose (7.5 mg) of zopiclone (Imovane®) is likely to cause central nervous system adverse events in the elderly.

Increased risk of recurrent thrombotic events

United Kingdom. The MHRA has announced that a clinical trial has shown that there is an increased risk of recurrent thrombotic events associated with rivaroxaban (Xarelto®) use compared to warfarin, in patients with antiphospholipid syndrome and a history of thrombosis.

Risk of rebound acid hypersecretion (RAHS)

New Zealand. Medsafe has announced that rebound acid hypersecretion (RAHS) has been reported in patients after stopping prolonged treatment with proton pump inhibitors (PPIs).

Potential risk of hemophagocytic lymphohistiocytosis (HLH)

Canada. Health Canada will work with the manufacturers of ipilimumab and nivolumab to determine appropriate label changes to the product safety information to include the potential risk of hemophagocytic lymphohistiocytosis (HLH). 

Risk of meningioma

Europe. The EMA’s PRAC has started a review of cyproterone (e.g. Androcur®) which will investigate the risk of meningioma, a rare, usually non-malignant tumour of the membranes covering the brain and spinal cord.

4 January 2020
Job Openings for B.Pharm or M.Pharm (9 posts) at CMSS, Ministry of Health & Family Welfare

Central Medical Services Society (CMSS) has been established with the approval of Cabinet on 24.08.2011 as a Central Procurement Agency (CPA) to streamline drug procurement and distribution system of Department of Health & Family Welfare (DoHFW), Ministry of Health and Family Welfare, Government of India and to eliminate existing deficiencies.

Subscribe with us




 


 

 

Do Not Forget to Verify

(Click on Subscription link in your inbox)

--------

whatsapp

 

Also Join:  youtube  telegram

Clini India

 

CLRI

Jobs by Category

Production Jobs

R&D Jobs

F&D Jobs

Sales & Marketing

QA Jobs

QC Jobs

Faculty Jobs

CRO Jobs

DRA Jobs

IPR Jobs

IT Jobs

Packaging Alerts

Hospital Pharmacist